Cargando…

Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis

BACKGROUND: The pathogenesis of invasive aspergillosis (IA) is still unknown, but its progression is rapid and mortality rate remains high. Bronchoalveolar lavage fluid (BALF) galactomannan (GM) analysis has been used to diagnose IA. This study is aimed at making an accurate estimate of the whole ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Xun-Jie, Li, Ya-Ping, Xie, Li-Min, Zhang, Hong-Lang, Qin, Yu-Shan, Guo, Xu-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723495/
https://www.ncbi.nlm.nih.gov/pubmed/33335924
http://dx.doi.org/10.1155/2020/5434589
_version_ 1783620349435314176
author Cao, Xun-Jie
Li, Ya-Ping
Xie, Li-Min
Zhang, Hong-Lang
Qin, Yu-Shan
Guo, Xu-Guang
author_facet Cao, Xun-Jie
Li, Ya-Ping
Xie, Li-Min
Zhang, Hong-Lang
Qin, Yu-Shan
Guo, Xu-Guang
author_sort Cao, Xun-Jie
collection PubMed
description BACKGROUND: The pathogenesis of invasive aspergillosis (IA) is still unknown, but its progression is rapid and mortality rate remains high. Bronchoalveolar lavage fluid (BALF) galactomannan (GM) analysis has been used to diagnose IA. This study is aimed at making an accurate estimate of the whole accuracy of BALF-GM in diagnosing IA. METHODS: After a systematic review of the study, a bivariate meta-analysis was used to summarize the specificity (SPE), the sensitivity (SEN), the positive likelihood ratios (PLR), and the negative likelihood ratios (NLR) of BALF-GM in diagnosing IA. The overall test performance was summarized using a layered summary receiver operating characteristic (SROC) curve. Subgroup analysis was performed to explore the heterogeneity between studies. RESULTS: A total of 65 studies that are in line with the inclusion criteria were included. The summary estimates of BALF-GM analysis are divided into four categories. The first is the proven+probable vs. possible+no IA, with an SPE, 0.87 (95% CI, 0.85-0.98); SEN, 0.81 (95% CI, 0.76-0.84); PLR, 9.78 (5.78-16.56); and NLR, 0.20 (0.14-0.29). The AUC was 0.94. The BALF-GM test for proven+probable vs. no IA showed SPE, 0.88 (95% CI, 0.87-0.90); SEN, 0.82 (95% CI, 0.78-0.85); PLR, 6.56 (4.93-8.75); and NLR, 0.24 (0.17-0.33). The AUC was 0.93. The BALF-GM test for proven+probable+possible vs. no IA showed SPE, 0.82 (95% CI, 0.79-0.95); SEN, 0.59 (95% CI, 0.55-0.63); PLR, 3.60 (2.07-6.25); and NLR, 0.31 (0.15-0.61). The AUC was 0.86. The analyses for others showed SPE, 0.85 (95% CI, 0.83-0.87); SEN, 0.89 (95% CI, 0.86-0.91); PLR, 6.91 (4.67-10.22); and NLR, 0.18 (0.13-0.26). The AUC was 0.94. CONCLUSIONS: The findings of this BALF-GM test resulted in some impact on the diagnosis of IA. The BALF-GM assay is considered a method for diagnosing IA with high SEN and SPE. However, the patients' underlying diseases may affect the accuracy of diagnosis. When the cutoff is greater than 1, the sensitivity will be higher.
format Online
Article
Text
id pubmed-7723495
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-77234952020-12-16 Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis Cao, Xun-Jie Li, Ya-Ping Xie, Li-Min Zhang, Hong-Lang Qin, Yu-Shan Guo, Xu-Guang Biomed Res Int Research Article BACKGROUND: The pathogenesis of invasive aspergillosis (IA) is still unknown, but its progression is rapid and mortality rate remains high. Bronchoalveolar lavage fluid (BALF) galactomannan (GM) analysis has been used to diagnose IA. This study is aimed at making an accurate estimate of the whole accuracy of BALF-GM in diagnosing IA. METHODS: After a systematic review of the study, a bivariate meta-analysis was used to summarize the specificity (SPE), the sensitivity (SEN), the positive likelihood ratios (PLR), and the negative likelihood ratios (NLR) of BALF-GM in diagnosing IA. The overall test performance was summarized using a layered summary receiver operating characteristic (SROC) curve. Subgroup analysis was performed to explore the heterogeneity between studies. RESULTS: A total of 65 studies that are in line with the inclusion criteria were included. The summary estimates of BALF-GM analysis are divided into four categories. The first is the proven+probable vs. possible+no IA, with an SPE, 0.87 (95% CI, 0.85-0.98); SEN, 0.81 (95% CI, 0.76-0.84); PLR, 9.78 (5.78-16.56); and NLR, 0.20 (0.14-0.29). The AUC was 0.94. The BALF-GM test for proven+probable vs. no IA showed SPE, 0.88 (95% CI, 0.87-0.90); SEN, 0.82 (95% CI, 0.78-0.85); PLR, 6.56 (4.93-8.75); and NLR, 0.24 (0.17-0.33). The AUC was 0.93. The BALF-GM test for proven+probable+possible vs. no IA showed SPE, 0.82 (95% CI, 0.79-0.95); SEN, 0.59 (95% CI, 0.55-0.63); PLR, 3.60 (2.07-6.25); and NLR, 0.31 (0.15-0.61). The AUC was 0.86. The analyses for others showed SPE, 0.85 (95% CI, 0.83-0.87); SEN, 0.89 (95% CI, 0.86-0.91); PLR, 6.91 (4.67-10.22); and NLR, 0.18 (0.13-0.26). The AUC was 0.94. CONCLUSIONS: The findings of this BALF-GM test resulted in some impact on the diagnosis of IA. The BALF-GM assay is considered a method for diagnosing IA with high SEN and SPE. However, the patients' underlying diseases may affect the accuracy of diagnosis. When the cutoff is greater than 1, the sensitivity will be higher. Hindawi 2020-11-30 /pmc/articles/PMC7723495/ /pubmed/33335924 http://dx.doi.org/10.1155/2020/5434589 Text en Copyright © 2020 Xun-Jie Cao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cao, Xun-Jie
Li, Ya-Ping
Xie, Li-Min
Zhang, Hong-Lang
Qin, Yu-Shan
Guo, Xu-Guang
Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
title Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
title_full Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
title_fullStr Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
title_full_unstemmed Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
title_short Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
title_sort diagnostic accuracy of bronchoalveolar lavage fluid galactomannan for invasive aspergillosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723495/
https://www.ncbi.nlm.nih.gov/pubmed/33335924
http://dx.doi.org/10.1155/2020/5434589
work_keys_str_mv AT caoxunjie diagnosticaccuracyofbronchoalveolarlavagefluidgalactomannanforinvasiveaspergillosis
AT liyaping diagnosticaccuracyofbronchoalveolarlavagefluidgalactomannanforinvasiveaspergillosis
AT xielimin diagnosticaccuracyofbronchoalveolarlavagefluidgalactomannanforinvasiveaspergillosis
AT zhanghonglang diagnosticaccuracyofbronchoalveolarlavagefluidgalactomannanforinvasiveaspergillosis
AT qinyushan diagnosticaccuracyofbronchoalveolarlavagefluidgalactomannanforinvasiveaspergillosis
AT guoxuguang diagnosticaccuracyofbronchoalveolarlavagefluidgalactomannanforinvasiveaspergillosis